Thermo Fisher Scientific Inc. (TMO)
Thermo Fisher Scientific, Inc. provides analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. The company operates its business through four segments: Analytical Technologies, Specialty Diagnostics, Life Sciences Solutions and Laboratory Products and Services. The Analytical Technologies segment is engaged in instruments, reagents, consumables, software and services that are used for applications in the laboratory on the production line and in the field. The Specialty Diagnostics segment offers diagnostic test kits, reagents, culture media, instruments and associated products in order to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The Life Sciences Solutions segment enable, simplify and accelerate a broad spectrum of biological research of genes, proteins and cells within academic and life science research, clinical research and commercial applications. The Laboratory Products and Services segment offers virtually everything needed for the laboratory. Thermo Fisher Scientific was founded in November, 2006 and is headquartered in Waltham, MA.
|Market Price at 19-01-2018||$213.51|
|Price to Earnings Ratio||17.06|
|Market Capitalisation||$85,616.44 (million)|
|Return on Equity (ROE)||15.26%|